Boehringer May Face More Sanctions In Pradaxa MDL

A week after hitting Boehringer Ingelheim International GmbH with a nearly $1 million penalty for discovery abuses, an Illinois federal judge ruled Wednesday that the drugmaker may be slapped with even...

Already a subscriber? Click here to view full article